Drugs / KWA-0711
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02434835 | ? → May 2015 | — | Kissei Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 25 trials · 2 met primary | ||||||
| Phase 2 | NCT02343978 | Dec 2014 → May 2015 | constipation disorder | Kissei Pharmaceutical Co., Ltd. | Completed | Met primary |
| Phase 2 | NCT02281630 | Oct 2014 → Apr 2015 | constipation disorder | Kissei Pharmaceutical Co., Ltd. | Completed | Met primary |
| Phase 2 | NCT01937663 | ? → Jan 2014 | constipation disorder | Kissei Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 2 | NCT01938196 | ? → Jan 2014 | constipation disorder | Kissei Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
| Phase 2 | NCT01600001 | — | constipation disorder | Kissei Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KWA-0711 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02343978 ↗ |
| Route | Oral | “single oral dose” NCT02434835 ↗ |